Interview with Petr Tor, Country Director, Stallergenes Czech Republic
Mr. Tor, prior to joining Stallergenes in 2010, you had been with MSD for nearly two decades. After such a prolonged experience at a major global pharma player, why did…
Wörwag Pharma is a medium-size family business created in 1965. The company is now operating in 40 countries and distributing products to over 104 international destinations, while managing to maintain the values of a family business. The future goals are determined by the basic philosophy: self-developed products and expertise, and OTC and generic medicines intended to enhance the well-being of patients.
For 40 years Wörwag Pharma stands for competence and expertise in the fields of biofactors and generics. We have established our reputation in Czech Republic and Slovakia as a specialist in the treatment of diabetes and its accompanying disorders.
Biofactors (vitamins and mineral supplements), preparations for polyneuropathy, and generics with excellent cost-benefit ratios: the broad product range of Wörwag Pharma. High quality medication, modern active substances and successful use of the medications in advanced therapeutic concepts in the fields of diabetic accompanying disorders confirm that Wörwag Pharma is an expert partner in science and practice.
Thinking and working globally is not a marketing strategy as far as we are concerned, but a way of living our profession every day – and it is at the same time, a challenge. Our task every day is to overcome long distances and cultural differences. With success!
Contact
Wörwag Pharma GmbH & Co. KG
Stolárska 35 – 831 06 Bratislava
Tel.: +421 (2) 44 88 99 20
Fax: +421 (2) 44 88 05 71
E-mail: info@woerwagpharma.sk
Wörwag Pharma GmbH & Co. KG
Bucharova 2657/12, Stodůlky – 158 00 Praha 5
Tel: +420 226 226 360
E-mail: info@woerwagpharma.cz
Mr. Tor, prior to joining Stallergenes in 2010, you had been with MSD for nearly two decades. After such a prolonged experience at a major global pharma player, why did…
Mr. Pfannenschmidt, you have been working for Boehringer Ingelheim for three decades, outlasting several company chairman and witnessing the birth and evolution of the corporate vision “Value through Innovation”. Before…
Mr. Bruzl, we often interview pharmaceutical managers that studied medicine, pharmaceutical science, or business—we do not interview many managers that have a background in law. How did you find yourself…
Infirmary and ultimately leading to a position heading the Czech Republic and Slovakian organization for Janssen. Can you begin by introducing yourself to our readers and giving them an overview…
Mr. Gyürüsi, Gedeon Richter is a 111-year-old company that is synonymous with the Central and Eastern European pharma industry. The business has been present in Czechoslovakia since 1956, and has…
Dr. Janda, can you please begin by introducing our readers to the ACRO-CZ, and explicate its mission on this market? Mimicking the European standards, we also wanted to connect all…
The Czech Republic is home to Apotex’s oldest branch within a Europe, established in 1992. You yourself joined the organization in 1993. What has been this company’s growth trajectory in…
Mr. Bartoš, you are celebrating your 15th anniversary with Merck this year, and your international career has offered you the opportunity to work throughout Europe. Over these years, how have…
Mr. Pospíšil, you have quite an interesting background, with a degree in agricultural economy engineering. You eventually left the field in 1991 to consult for Lundbeck, building the business here.…
Dr. Zörner, can you please begin by introducing our readers to the CAFF (Czech Association of Pharmaceutical Firms), and explicate its key activities and mission? We represent 24 companies in…
Mr. Březovký, can you begin with an introduction to SUKL and its role within the Czech Republic’s complex regulatory environment? I would like to begin by noting that I have…
In the Czech Republic, homeopathic medicines were prohibited during the communistic period, but found resurgence after 1989. Can you give us an overview of the development of this form of…
See our Cookie Privacy Policy Here